Abstract
Metallo-beta-lactamases have a hydrolysing activity against various beta-lactams including carbapenems, and beta-lactamase inhibitors such as clavulanic acid and sulbactum. Infections caused by metallo-beta-lactamase producing gram-negative bacteria are becoming a serious problem in Japanese clinical settings despite the recent progress in medical technology. Current screening methods can not distinguish metallo-beta-lactamase producers from those producing AmpC beta-lactamase. Here we show a convenient method of detecting metallo-beta-lactamase producers using a thiol compound(2-mercaptopropionic acid) as well as a PCR method with metallo-beta-lactamase gene specific primers.
| Original language | English |
|---|---|
| Pages (from-to) | 109-116 |
| Number of pages | 8 |
| Journal | Rinsho byori. The Japanese journal of clinical pathology |
| Volume | Suppl 111 |
| Publication status | Published - 01-2000 |
| Externally published | Yes |
All Science Journal Classification (ASJC) codes
- General Medicine
Fingerprint
Dive into the research topics of 'Gene examination methods (detection and genotyping of resistant genes)--metallo-beta-lactamase'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver